You are here: Industry Insights > India

News List

Indian CMO market hotbed for private equity investment, says report europeanpharmaceuticalreview
August 18, 2020
A report suggests that India’s CMO market has recently attracted investment from global private equity firms due to favourable government policies.
India’s CMO market is hotbed for global PE investment: GlobalData expresspharma
August 18, 2020
Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small molecule API hotspots such as in the US and China.
Pharma industry requests government to delay release of new NLEM list expresspharma
August 18, 2020
Industry stakeholders also presented issues related to the NLEM list 2015 and suggested course corrective measures in the upcoming NLEM list.
Race to find a viable vaccine: Can Indian firms rise to the challenge? expresspharma
August 18, 2020
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to develop and manufacture vaccines.
India in talks with developer of Russian COVID-19 vaccine: The Indian Express expresspharma
August 18, 2020
Russian regulators recently approved the Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, Moscow.
Ajinomoto Bio-Pharma expands small molecule manufacturing capabilities in India expresspharma
August 14, 2020
Ajinomoto Bio-Pharma Services announced expansion of small molecule manufacturing capabilities with the addition of a new production facility in Visakhapatnam, India.
Mission Atma Nirbhar in pharma expresspharma
August 13, 2020
Let us keep in mind that India is not a weak economy. We are a strong economy. Despite pressure due to COVID-19, terrorist problem and threat of war from China, India has proven its strength.
Success of indigenous COVID-19 vaccines will make access easy and affordable in India: GlobalData expresspharma
August 12, 2020
India is making rapid progress in the development of indigenous COVID-19 vaccines. With an increase in the number of COVID-19 positive cases, their success will make access easy and affordable for Indians, says GlobalData, data and analytics company.
Prices of remdesivir and favipiravir being monitored in India, says report europeanpharmaceuticalreview
August 10, 2020
Regulatory bodies in India are tracking the cost of remdesivir and favipiravir amid the COVID-19 pandemic but should consider price caps, a report has suggested.
OTC healthcare products: A growth area for India Pharma Inc expresspharma
August 10, 2020
Dr Atish Rodge, MD & Founder, Allmpus Laboratories points out that India is an increase in demand for OTC healthcare products and informs that increasing health expenditure due to the pandemic, a sudden rise in lifestyle diseases, and massive ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 33 34 Next page